SERIES A COMMON STOCK PURCHASE WARRANT BRICKELL BIOTECH, INC.Common Stock Purchase Warrant • February 28th, 2020 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 28th, 2020 Company IndustryTHIS SERIES A COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after February 20, 2020 (the “Initial Exercise Date”) and on or prior to the close of business on February 20, 2025, (the “Termination Date”, provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day (as defined below)) but not thereafter, to subscribe for and purchase from BRICKELL BIOTECH, INC., a Delaware corporation (the “Company”), up to 606,420 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).
SERIES B COMMON STOCK PURCHASE WARRANT BRICKELL BIOTECH, INC.Common Stock Purchase Warrant • February 28th, 2020 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances)
Contract Type FiledFebruary 28th, 2020 Company IndustryTHIS SERIES B COMMON STOCK PURCHASE WARRANT (the “Warrant”) certifies that, for value received, LINCOLN PARK CAPITAL FUND, LLC, an Illinois limited liability company or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after August 20, 2020 (the “Initial Exercise Date”) and on or prior to the close of business on August 20, 2025, (the “Termination Date”, provided, however, that if such date is not a Trading Day, the Termination Date shall be the immediately following Trading Day (as defined below)) but not thereafter, to subscribe for and purchase from BRICKELL BIOTECH, INC., a Delaware corporation (the “Company”), up to 1,556,420 shares (as subject to adjustment hereunder, the “Warrant Shares”) of Common Stock. The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).